Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry

•Covid-19 vaccine hesitancy in surveyed persons with MS in Switzerland was very low.•Hesitation to vaccinate was most often a personal preference.•Older age and regular visits to healthcare professionals were negatively associated with hesitancy.•A history of positive Covid-19 test was positively associated with hesitancy.•Covid-19 vaccination usually had mild side effects and rarely affected MS symptoms.